In addition, CXCR2 regulated Treg cell migration into malignant pleural effusions (MPEs) via the miR141-CXCL1-CXCR2 pathway, decreasing the median survival of NSCLC patients with MPE (150). The gene discussed is CXCR2; the disease is non-small cell lung carcinoma.